Map the options
Multiple rounds of research, patent and technology analysis covered the full landscape.
Research and expert input that holds up at decision time.
The evidence your team needs to move forward with confidence.
Products designed to keep your team informed and ready to act.
Briefs, reports, case studies and media from our research team.
A global pharmaceutical company wanted better process analytical technologies for its monoclonal antibody fill and finish operations. We screened the field, scored the best options and narrowed 80 technologies to a top 18.
The client is a prominent global pharmaceutical company focused on optimizing biomanufacturing for monoclonal antibodies. It wanted to guide both manufacturing partners and in-house thaw to fill and finish operations.
Prescouter was asked to find analytical devices with process analytical technology capabilities for antibody fill and finish, as demand grows for continuous biomanufacturing and late-stage regulatory scrutiny rises.
Growing pressure to monitor in real time.
Higher expectations in late bioprocessing.
Shared standards for partners and in-house.
Multiple rounds of research, patent and technology analysis covered the full landscape.
Experts helped surface innovative solutions with real process analytical capability.
A custom scoring matrix ranked recommended technologies on quantitative criteria.
Prescouter identified 80 technologies with process analytical capabilities, analyzed 45 in depth and presented a top 18 after quantitative scoring. The client gained a clear view of which solutions to integrate into its current workflow.
Across the fill and finish process.
Built on research and expert input.
Ready to evaluate for the workflow.
Better process data starts with choosing the right instruments. A scored shortlist turns a crowded field into clear next steps.
Find and score the analytical tools that fit your manufacturing workflow. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]Pick a time on our calendar right now.
If you’d like to know the outcome of your submission, please leave your email address